Eagle Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.51M Buy
120,483
+2,662
+2% +$65.6K 0.02% 398
2024
Q2
$2.65M Sell
117,821
-1,939
-2% -$44.8K 0.01% 449
2024
Q1
$3.48M Sell
119,760
-11,068
-8% -$371K 0.02% 429
2023
Q4
$4.67M Buy
130,828
+49,528
+61% +$1.84M 0.03% 381
2023
Q3
$3.56M Buy
81,300
+593
+0.7% +$28.9K 0.02% 398
2023
Q2
$3.98M Buy
80,707
+6,040
+8% +$278K 0.02% 381
2023
Q1
$3.09M Buy
74,667
+2,280
+3% +$94.6K 0.02% 395
2022
Q4
$3.25M Sell
72,387
-217,228
-75% -$9.07M 0.02% 388
2022
Q3
$11.3M Sell
289,615
-366,277
-56% -$16.8M 0.07% 223
2022
Q2
$26.8M Sell
655,892
-74,167
-10% -$3.51M 0.17% 157
2022
Q1
$47.9M Buy
730,059
+1,805
+0.2% +$117K 0.25% 130
2021
Q4
$49.9M Sell
728,254
-82,373
-10% -$5.99M 0.22% 148
2021
Q3
$56.4M Sell
810,627
-45,178
-5% -$3.48M 0.25% 144
2021
Q2
$67.9M Sell
855,805
-215,128
-20% -$15.6M 0.29% 130
2021
Q1
$68.7M Buy
1,070,933
+117,979
+12% +$7.27M 0.3% 128
2020
Q4
$53M Buy
952,954
+334,098
+54% +$14.4M 0.3% 115
2020
Q3
$24.8M Buy
618,856
+204,827
+49% +$8.69M 0.13% 199
2020
Q2
$18.4M Buy
414,029
+308,408
+292% +$13.4M 0.1% 223
2020
Q1
$3.55M Sell
105,621
-49,621
-32% -$1.78M 0.02% 396
2019
Q4
$5.05M Sell
155,242
-7,870
-5% -$224K 0.02% 405
2019
Q3
$4.07M Sell
163,112
-79,567
-33% -$2.27M 0.02% 435
2019
Q2
$7.24M Buy
242,679
+6,180
+3% +$180K 0.04% 355
2019
Q1
$6.33M Buy
+236,499
New +$7.18M 0.03% 373
2016
Q4
Sell
-209,345
Closed -$3.31M 631
2016
Q3
$3.31M Buy
+209,345
New +$3.22M 0.02% 480

Other funds holding ATRC

Eagle Asset Management's ATRC Position: Q3 2024 in Review

Eagle Asset Management increased its AtriCure (ATRC) stake by 2.3% in Q3 2024, buying an estimated $65.6K and bringing the position to 120,483 shares worth $4.51M. The position accounts for 0.02% of the portfolio, ranked #398.

Eagle Asset Management first reported a position in ATRC in Q3 2016 and has held it in 24 quarters since. The position peaked at $68.7M in Q1 2021. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • Eagle Asset Management held 120,483 shares of AtriCure worth $4.51M as of Q3 2024.
  • Eagle Asset Management bought 2,662 AtriCure shares in Q3 2024, an estimated $65.6K.
  • AtriCure made up 0.02% of Eagle Asset Management's portfolio in Q3 2024, its #398 holding.
  • Eagle Asset Management first reported a position in AtriCure in Q3 2016 and has held it in 24 quarters since.
  • Eagle Asset Management's AtriCure position peaked at $68.7M in Q1 2021.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.